23 May 2013
Keywords: amgen, 3rd-qtr, profit, plunges, 210m, back, esa
Article | 05 November 2007
World biotechnology major Amgen's third-quarter 2007 profit was hit by lower revenue from its portfolio of anemia drugs, after the US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
29 October 2007
22 May 2013
© 2013 thepharmaletter.com